Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

海安瑞 - NMPA Drug Approval Details

Approvals/NMPA/海安瑞

Approved

中药

海安瑞

河北龙海药业有限公司🇨🇳 National Medical Products Administration

Approval Date: Aug 25, 2020
Approval ID: 7LeaeG6LLLU
Company: 河北龙海药业有限公司
Type: 中药

Approval Details

Approval Id: 7LeaeG6LLLU
Approval Number: 国药准字Z13022447
Generic Name: 八珍益母片
Brand Name: 海安瑞
Drug Type: 中药
Dosage Form: 片剂
Strength: 每片重0.32g
Reg Date: 2020-08-25
Company Name: 河北龙海药业有限公司
Company Address: 石家庄经济技术开发区塔西大街6号
Production Company Name: 河北龙海药业有限公司;石家庄东方药业股份有限公司
Production Company Address: 石家庄经济技术开发区塔西大街6号；河北省石家庄高新区仓盛路528号
Company Detail Path: /organization/he-bei-long-hai-yao-ye-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 25, 2020

Approval ID

7LeaeG6LLLU

Type

中药

Back to NMPA Approvals